02Dec
UK Life Sciences and Healthcare Newsletter - December 2020: The UK National Security and Investment Bill
The UK has announced a bill proposing a new system to screen transactions for national security risk, separate from the system of merger review operated by the Competition and Markets Authority. The National Security and Investment Bill has been in the pipeline since the publication of the National Security Risk Assessment in 2015, but has been delayed due to Brexit and the COVID-19 pandemic....
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-53811/
Related
In Fortis Advisors LLC, v. Allergan W.C. Holding Inc., C.A. No. 2019-0159-NTZ (Del. Ch. May 14, 2020...
Read More >
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
Massachusetts Financial Services Co. (MFS) has reached a settlement of nearly $7 million in a lawsui...
Read More >
In the rapidly evolving landscape of COVID-19 response, many states, counties, and cities throughout...
Read More >
In its recent decision in R. v Secretary of State for Transport, the Court of Appeal ruled that the ...
Read More >
In late 2019, COVID-19 (more commonly known as the coronavirus) began to spread throughout mainland ...
Read More >